Stage IA Uterine Sarcoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stage IA Uterine Sarcoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT03422198

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

This randomized phase III trial studies short course vaginal cuff brachytherapy to see how well it works compared with standard of care vaginal cuff brachythera…

United States188 participantsStarted 2018-02-02

Treatment: Vaginal Cuff Brachytherapy, Short course vaginal cuff brachytherapy

All recent trials (19 shown)

Active — Not RecruitingPhase 1/2

NCT04140526

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal a…

United States733 participantsStarted 2020-09-16

Treatment: ONC-392, Pembrolizumab

TerminatedNot Applicable

NCT01367301

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

This pilot clinical trial studies radiation therapy, paclitaxel, and carboplatin in treating patients with uterine cancer. Radiation therapy uses high-energy x-…

United States14 participantsStarted 2011-07-08

Treatment: paclitaxel, carboplatin

Stage IA Uterine Sarcoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

All recent trials (19 shown)

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

All recent trials (19 shown)

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Remo…

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ova…

Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecologi…

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients Wit…

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Collecting Tumor Samples From Patients With Gynecological Tumors

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cance…

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer,…

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients…